FDA Inspection
AstraZeneca Nijmegen B.V.AstraZeneca Nijmegen B.V. – FDA Inspection, Sep 22, 2017
Record Details
This FDA Inspection record concerns AstraZeneca Nijmegen B.V., with an inspection on September 22, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 6972f213-31aa-4ac1-99aa-f1eef33a7a0c
Inspection Facts
- Inspection number
- 1036241
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of AstraZeneca Nijmegen B.V.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 10, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2019 | Not classified | Office of Inspections and Investigations | |
| September 10, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 5, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca Nijmegen B.V.
- FDA Inspection 1276715 - 2024-04-10
- FDA Inspection 1107865 - 2019-09-19
- FDA Inspection 1112441 - 2019-09-10
- FDA Inspection 936026 - 2015-06-05
- FDA Inspection 850854 - 2013-06-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.